TITLE

Biotech IPO Hopes Run Aground

AUTHOR(S)
Abrams, Sandra Lea
PUB. DATE
October 2005
SOURCE
Investment Dealers' Digest;10/10/2005, Vol. 71 Issue 38, p13
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the poor performance of initial public offerings (IPOs) from the biotechnology industry in the United States. Reasons behind the poor performance of biotech IPOs; Total amount raised by biotechnology companies that launched IPOs in 2005.
ACCESSION #
18537842

 

Related Articles

  • European Biotech Recovers, IPOs Expected.  // BioPharm International;Jun2004, Vol. 17 Issue 6, p10 

    Reports on a study conducted by Ernst & Young Inc. which found that Europe's biotechnology industry may be recovering after a decline in 2003. Percentage decline in revenues, workers and research and development spending in the industry; Information on potential companies who will offer initial...

  • IN SEARCH OF SUPPORTERS. Quinlivan, Beth // BRW;8/19/2004, Vol. 26 Issue 32, p26 

    Presents the outcomes of a survey of Australia's biotechnology sector in 2003-04. Market conditions for the companies; Amount raised by biotechnology, pharmaceutical and medical device companies from initial public offerings and secondary issues; Number of mergers formed between smaller...

  • 2005: Biotech partners up. Lawrence, Stacy // Nature Biotechnology;Feb2006, Vol. 24 Issue 2, p126 

    The article examines the financial performance of the global biotechnology industry in 2005. It includes information on the stock market performance, financing, partnership deals, venture capital investment, and initial public offerings within the industry. The trends among biotechnology...

  • FINANCINGS ROUNDUP.  // BioWorld Today;4/20/2010, Vol. 21 Issue 75, p4 

    This section offers news briefs on financing deals in the biotechnology industry including the registered direct offering of EntreMed Inc. that raised three million U.S. dollars and a plan by RegeneRx Biopharmaceuticals Inc. to raise 12 million U.S. dollars via a public offering of stocks and...

  • Financings Roundup.  // BioWorld Today;3/3/2011, Vol. 22 Issue 42, p2 

    This section offers news briefs related to financing deals in the biotechnology sector including the seven million Norwegian krone secured by BerGenBio A/S from local Sarsia Seed and Development Funds to continue its cancer research activities, the warrants exercised by the largest institutional...

  • Biotechs await IPO 'boomlet'. Mitchell, Pete // Nature Biotechnology;Oct2003, Vol. 21 Issue 10, p1116 

    Reports on the emergence of initial public offering (IPO) plans in the biotechnology industry. Performance of stocks of small-capital biotechnology companies; IPO valuation; List of U.S.-based companies who announced IPO plans.

  • ChemoCentryx Prices $45M IPO; Platforms, Partners Prevail. Morrison, Trista // BioWorld Today;2/9/2012, Vol. 23 Issue 18, p1 

    This article reports on the 45 million U.S. dollars raised by biotechnology firm ChemoCentryx Inc. in its initial public offering (IPO). The success is attributed to the IPO of other biotechnology firms including Cempra Inc. and Verastem Inc. Information is given on the company's key products....

  • Senomyx IPO Shares Discounted More Than 50 Percent. Webb, Marion // San Diego Business Journal;6/28/2004, Vol. 25 Issue 26, p3 

    Reports that San Diego, California-based biotechnology company Senomyx Inc. has priced its initial public offering (IPO) below the expected range. Price of the IPO per share; Difficulty in the differentiation by biotechnology companies from the rest due to the selectiveness of investors;...

  • Soaring Interest In RNA Field Nets Exiqon $62.7 Million IPO. Sheridan, Cormac // BioWorld International;6/6/2007, Vol. 12 Issue 23, p1 

    The article reports that Exiqon A/S, a specialist in messenger ribonucleic acid (mRNA) and microRNA (miRNA) based in Vedbaek, Denmark has raised Danish Krones (DKK) 347.6 million in an initial public offering on the Copenhagen Stock Exchange. The company issued 8.69 million shares, priced at...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics